Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)   SEPTEMBER-OCTOBER 2008 , Volume 13 , Number 5; Page(s) 264 To 267.
 
Paper: 

OUTPATIENT TREATMENT OF MIGRAINE HEADACHE, CAN WE USE A DEXAMETHASONE CONTAINING REGIMEN?

 
 
Author(s):  HAMZEHEI MOGHADAM A., ZAREEI SEYED HOSSEIN*, SEYF ALDINI R., SALEHIFAR V.
 
* SHAFA MEDICAL CENTER, NEUROSCIENCES RESEARCH CENTER, KERMAN UNIVERSITY OF MEDICAL SCIENCES, KERMAN, IRAN
 
Abstract: 

BACKGROUND: This research is aimed at determining the efficacy of intravenous dexamethasone and metoclopramide for treatment of acute migraine. Dexamethasone is a well-known drug for treatment of long lasting and recurrent migraine headaches. Metoclopramide is also used singularly or as an adjunct to treat the migraine attacks.
METHODS: In a simple randomized study, patients with acute migraine were administered either intravenous dexamethasone and metoclopramide or intramuscular dihydroergotamine. Headache and concurrent symptoms were rated at baseline and 1, 2, 4 and 24 hours post-injection.
RESULTS: Analysis of headache severities indicated significant alleviation in both groups with time (p<0.001). Side effects and concurrent symptoms did not show any significant difference between the two studied groups.
CONCLUSIONS: In emergency department, intravenous dexamethasone and metoclopramide may be considered as an effective and available treatment with few side effects especially for patients with long-lasing and intractable migraine attacks; however, it must be used limitedly.

 
Keyword(s): DEXAMETHASONE, METOCLOPRAMIDE, DIHYDROERGOTAMINE, MIGRAINE
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 88
 
Latest on Blog
Enter SID Blog